Meeting
2014 ASCO Annual Meeting
Circulating tumor DNA (ctDNA) as a molecular monitoring tool in metastatic breast cancer (MBC).
Authors
Laura Katherine Austin
Thomas Jefferson University Hospital, Philadelphia, PA
Laura Katherine Austin , Paolo Fortina , Dragan Sebisanovic , LaiMun Siew , Aubrey Zapanta , AmirAli Talasaz , Massimo Cristofanilli
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 11093)
DOI
10.1200/jco.2014.32.15_suppl.11093
Abstract #
11093
Poster Bd #
375
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Detection, dynamic monitoring, and resistance mechanism exploration of genomic alterations in circulating cell free tumor DNA (ctDNA) in Chinese metastatic breast cancer (mBC).
First Author: Huiping Li
Poster
2020 ASCO Virtual Scientific Program
The landscape of genomic alterations detected in serial circulating tumor DNA (ctDNA) in clinical progressive metastatic breast cancer.
First Author: Saya Jacob
Poster
2019 ASCO Annual Meeting
A landscape of circulating tumor DNA in esophageal adenocarcinoma and squamous cell carcinoma.
First Author: Kabir Mody
Poster
2018 ASCO Annual Meeting
Use of cell-free DNA for management of breast and lung cancer by academic and community providers.
First Author: Roby Antony Thomas